IN THIS ISSUE
Legislation & Regulation
Richard Mark Kirkner

David Balto, formerly FTC

One of the purposes of health care reform was to create more competition, and the recent spate of acquisitions works against that.

Medication Management
Thomas Reinke

Elliott Antman, MD

This knowledge won’t come cheap, as the system braces for new agents that could add another $42 billion to the nation’s drug bill.

Medical Device Monitor
Katherine T. Adams
Tomorrow's Medicine
Thomas Morrow, MD

The combination of a neprilysin inhibitor and an ARB rescued neprilysin inhibition from obscurity.

News & Commentary